Dr. Antonio Bedalov wins award for translational research

Dr. Antonio Bedalov is among the first three recipients of the University of Washington School of Pharmacy’s Ignition Awards. Bedalov will lead a study titled "Identification of Pharmacodynamic Biomarkers for Inhibitors of NAD-dependent Protein Deacetylases Using Mass Spectrometry."

Bedalov, of the Clinical Research Division, is also an attending physician in the transplant clinic at the Seattle Cancer Care Alliance and an assistant professor of medicine in the UW School of Medicine.

The Ignition Awards were created in partnership with the UW Institute of Translational Health Sciences. Total funding allotted this year was $80,000. The money was awarded to projects that show promise of leading to new grant applications or future pre-clinical and clinical studies.

Each winner will collaborate with a School of Pharmacy faculty member on their research project. This will allow the scientists to work together to advance their translational research in areas of drug delivery, transport, metabolism, pharmacokinetics or pharmacogenetics. Bedalov will collaborate with Dr. David Goodlett, associate professor of medicinal chemistry in the School of Pharmacy.

The other two recipients are the UW’s Dr. Christopher Goss, assistant professor of medicine/pulmonary and critical care medicine; and Dr. Hai Zhang, and assistant professor of restorative dentistry in the UW School of Dentistry.

The partner funding institution, ITHS, is an interdisciplinary program funded by the National Institutes of Health to advance translational research. Its goal is to make a positive impact on human health locally and globally by instigating collaborations between many groups, including academia, industry and government.